Jeane Silva, Augusta University, United States
Obesity is a significant risk factor for life-threatening diseases that increase morbidity and mortality rates. Currently, obesity is a worldwide epidemic, and the prevalence of obesity has been rising at unprecedented levels. The obesity rate among adults aged 20 and older is 40 [....] » Read More
Title : Empowering successful outcomes: Program strategies for clients using Anti-Obesity Medications (AOMs)
Bob Esquerre, Esquerre Fitness Group International, United States
In 2013, the American Medical Association officially recognized Obesity as a disease. By 2030, clinically defined obesity is projected to affect over one billion people globally, representing a significant public health crisis. Defined by a body mass index (BMI) of 30 or higher, [....] » Read More
Title : Integrative medicine for obesity and pre-diabetes reduction
F Buck Willis, Belize Bible College, Punta Gorda, United States
Obesity is the #1 top risk factor for developing Type 2 Diabetes Mellitus (T2D), and this is the top comorbid condition. The CDC also reports that 35% of the American population in 2023 were diagnosed with Pre-Diabetes Mellitus (PDM) via HbA1c testing and half of that population [....] » Read More
Title : Redefining fitness: Time-efficient strategies for active living with AOM medications
Ann Gilbert, BS Purdue University, United States
As the use of anti-obesity medications (AOMs) continues to grow, so does the need to adopt fitness strategies that complement their benefits while addressing the unique challenges faced by individuals on these treatments. This presentation focuses on breaking traditional exercise [....] » Read More
Title : Validation of omron percent body fat measuring instrument
Anand Shetty, University of St Mary, United States
Introduction: Obesity is a disease that can affect the normal life of an individual due to its effect on cardiovascular, renal, and orthopedic pathology. People become obese due to hereditary influence, nutritional deficit, high calorie consumption, and lack of physical activitie [....] » Read More
Title : Flattening the cost curve and improving health outcomes: Results from a weight management pilot program with a state employee health plan
Amy Laktash, FlyteHealth, United States
As novel anti-obesity medications (AOMs) like semaglutide and tirzepatide become more widely available, employers face increasing costs associated with these highly effective treatments. For example, the State of North Carolina recently ended coverage for GLP-1 medications, citin [....] » Read More
Title : Understanding and addressing the multifactorial nature of obesity: A comprehensive approach
Christina Campbell, Christina Campbell, DO, United States
Obesity is a complex, multifactorial condition influenced by an intricate interplay of dietary, lifestyle, genetic, and epigenetic factors. Effective weight management necessitates a deeper understanding of these root causes to develop targeted interventions that promote sustaina [....] » Read More
Title : Enhancing workplace productivity through health solutions: Data-driven insights on the impact of GLP-1 medications on focus, productivity, and absenteeism
Adam McBride, CEO, Eden Health International, United States
In today’s fast-paced professional environment, workplace productivity is significantly impacted by metabolic health, weight management, and chronic disease. This presentation explores how personalized treatments, particularly GLP-1 receptor agonist (GLP-1RA) medications, h [....] » Read More
Title : Predictors and moderators of treatment outcomes in a randomized clinical trial of cognitive behavioural therapy integrated with weight loss for people with disorders of recurrent binge eating and high BMI
Haider Mannan, Western Sydney University, Australia
Purpose: Understanding predictors and moderators of outcomes in trials of people with eating disorders (EDs) is important as it informs person-centred clinical practice. Thus, we investigated pre-treatment clinical features, and mid-therapy decrease in loss of control overeating [....] » Read More
Title : Smart fat: Physical exercise-induced mechanisms for obesity prevention
Fabiana Sant Anna Evangelista, University of Sao Paulo, Brazil
Disruptions of biological processes operating within adipose tissue can disturb healthy systemic physiology and develop metabolic diseases such as obesity and type 2 diabetes. Uncovering the biomolecular processes regulating adipocyte functionality can be the key to mitigating me [....] » Read More
Title : Wellness from within: Mini mindset shifts to create lasting change
Colleen Lindsey, Leading Notes, United States
Dr. Colleen Lindsey loves helping people improve their lives. Using her 150-pound weight-loss journey to catapult further change in her own life, she has identified six steps necessary for change to occur for people. CHANGE happens when people understand themselves, adjust min [....] » Read More
Title : The incidence of hypoglycemia and its risk factors among diabetic patients at prince mohammed bin abdulaziz national guard hospital In Al-Madinah Al-Munawwarh, Saudi Arabia
Areej Aljumaidi, NGHA, Saudi Arabia
Aims: This study aims to investigate the incidence rate and risk factors for hypoglycemia among individuals with type 1 (T1DM) and type 2 diabetes (T2DM) in Saudi Arabia receiving insulin treatment. Methods: A cross-sectional study was conducted at Prince Mohammed bin Abdulaziz N [....] » Read More